InsightsPremium

Barry Flannelly

EVP & GM USA at Incyte

Barry Flannelly joined Incyte as Executive Vice President, Business Development and Strategic Planning in August 2014 and was appointed General Manager, US in June 2015. Dr. Flannelly has been working in oncology since 1987, and began his career in the pharmaceutical and biotech industry at Rhone-Poulenc Rorer, which later became Sanofi-Aventis. He has since had roles of increasing responsibility at Novartis Pharmaceuticals Corporation, Abraxis Oncology, Onyx Pharmaceuticals, Inc., and Nektar Therapeutics. During his career, he has held positions in medical affairs, strategic planning, and commercial operations, including head of sales, head of marketing, and business development. He earned his Doctor of Pharmacy from the University of Maryland School of Pharmacy, his Master in Business Administration from the University of Baltimore, and his Bachelor of Science in Pharmacy from Massachusetts College of Pharmacy.

Roles

  • EVP & GM USA

    August, 2014 - present

Social

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.